This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has a ceiling value of $43,917.82 and an ultimate completion date of September 13, 2024. It is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 30 MG TABLET. The contract has a ceiling value of $24,816.64 and an ultimate completion date of August 30, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded this contract to provide the specified pharmaceutical product...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $18,700.90, is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm-fixed-price delivery order with an ultimate completion date of September 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,761.62 firm-fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans'...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has a ceiling value of $49,151.46 and an ultimate completion date of October 8, 2024. It is a firm fixed-price contract. This is a child contract under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a prescription medication. The contract has a ceiling value of $33,890.35 and an ultimate completion date of September 19, 2024. It is a firm fixed-price contract and does not have a set-aside designation. As a key supplier to various federal healthcare programs, including those...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $66,782.90 firm fixed-price contract is for the supply of the pharmaceutical product RINVOQ ER 45 MG TABLET UU 28S. The contract has an ultimate completion date of October 9, 2024. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical commodities to various...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 30 MG TABLET UU 30S. The contract has a ceiling value of $131,624.89 and a completion date of September 27, 2024. It is a firm fixed-price contract and was not set aside for any specific business type. Amerisourcebergen is a for-profit organization that has been awarded numerous federal contracts and Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG TABLET. The contract has a ceiling value of $32,806.21 and a completion date of August 9, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the specified pharmaceutical product to support the medical needs of military treatment facilities and other federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, with a ceiling value of $20,696.09. The contract provides for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The order has a firm fixed-price pricing type and an ultimate completion date of October 11, 2024. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has been awarded numerous...